Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (147)
  2. Journal Article (130)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (293)
  3. Thoracic Oncology (293)
  4. Surgery (114)
  5. Department of Pathology and Laboratory Medicine (98)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (50)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (62)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (12)
  6. Mosby Elsevier (10)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying the optimal radiation dose in locally advanced non-small cell lung cancer (NSCLC) treated with definitive radiation therapy without concurrent chemotherapy
    Meeting Abstract

    Oro, F.; Sonnick, M.; Wu, A. J.; Shi, W.; Zhang, Z.; Gelblum, D.; Paik, P.; Yorke, E. D.; Rosenzweig, K.; Chaft, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival
    Journal Article

    Ujiie, H.; Kadota, K.; Chaft, J. E.; Buitrago, D.; Sima, C. S.; Lee, M. C.; Huang, J.; Travis, W. D.; Rizk, N. P.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Occult primary non-small cell lung cancer with mediastinal lymph node involvement
    Meeting Abstract

    Romesser, P. B.; Rimner, A.; Foster, A.; Chaft, J. E.; Huang, J.; Jones, D. R.; Wu, A. J.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Prognostic impact of EGFR and KRAS mutations in patients with lung adenocarcinoma treated with definitive radiation therapy
    Meeting Abstract

    Oro, F.; Sonnick, M.; Wang, H.; Zakowski, M.; Wu, A. J.; Chaft, J. E.; Paik, P.; Tsang, M.; Hsu, M.; Rosenzweig, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Phase 2 study of MEDI4736 in patients with PD-L1+ locally advanced or metastatic stage IIIb-IV NSCLC treated with >= 2 prior regimens (ATLANTIC)
    Meeting Abstract

    Garassino, M. C.; Barlesi, F.; Chaft, J.; Shi, K.; Ibrahim, R.; Stockman, P.; Ballas, M.; Rizvi, N. A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of PD-L1 expression in metachronous tumor samples and FDG-PET as a predictive biomarker in Ph2 study (FIR) of atezolizumab (MPDL3280A)
    Meeting Abstract

    Chaft, J. E.; Chao, B.; Akerley, W. L.; Gordon, M.; Antonia, S. J.; Callahan, J.; Sandler, A.; Funke, R.; Li, Z.; Fredrickson, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Spatiotemporal effects on programmed death ligand 1 (PD-L1) expression and immunophenotype of non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kowanetz, M.; Koeppen, H.; Boe, M.; Chaft, J. E.; Rudin, C. M.; Zou, W.; Nickles, D.; Desai, R.; Nakamura, R.; Sandler, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase 1b study of the safety and antitumour activity of durvalumab (MEDI4736) + tremelimumab in advanced NSCLC
    Meeting Abstract

    Rizvi, N.; Balmanoukian, A.; Goldberg, S. B.; Chaft, J.; Sanborn, R. E.; Rebelatto, M. C.; Narwal, R.; Robbins, P. B.; Gu, Y.; Karakunnel, J. J.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save